To establish, support, and manage care centers, clinics, diagnostic labs, and rehabilitation facilities dedicated to the diagnosis, treatment, and long-term management of inherited metabolic disorders (IMDs) in urban, rural, and remote areas.

To promote awareness about IMDs through campaigns, workshops, and digital platforms, educating the public, healthcare professionals, and policymakers about early diagnosis, genetic counseling, and preventive measures.

To facilitate research into IMDs by collaborating with medical institutions, universities, and research organizations, and to fund studies on novel therapies, dietary management, and gene-based treatments.

To provide financial assistance, subsidized treatments, nutritional supplements, and medical equipment to individuals and families affected by IMDs, prioritizing marginalized and economically disadvantaged groups.

To collaborate with governments, international agencies, and NGOs to advocate for policies that improve access to newborn screening programs, specialized healthcare, and affordable orphan drugs for IMD patients.

To organize conferences, training programs, and skill-building workshops for healthcare professionals, caregivers, and patients to enhance knowledge about IMD management and psychosocial support.

To publish educational materials, guidelines, and multilingual resources (print, digital, and audiovisual) on IMDs for patients, families, and medical practitioners.

To establish a national registry of IMD patients to track epidemiological data, improve care coordination, and advance evidence-based policymaking.

To create support groups, helplines, and counseling services for patients and families to address emotional, social, and financial challenges associated with IMDs.

To raise funds through grants, donations, CSR partnerships, and fundraising events to sustain the organization’s initiatives and expand its reach.

To collaborate with genetic testing labs, biobanks, and research institutions to improve access to advanced diagnostic tools and personalized medicine for IMD patients.

To advocate for the inclusion of IMDs in national health programs, insurance schemes, and disability rights frameworks to ensure equitable care.

To engage in international partnerships for knowledge-sharing, capacity-building, and advocacy on rare metabolic disorders.

To undertake any other activities incidental or conducive to the above objectives, as permitted under applicable laws governing non-profit organizations.